Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Theseus Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +1 vs. Q4 2021
- Shares held
- 35.0M
- +123.7K (+0.4%) vs. Q4 2021
- Total value
- $402.8M
- −$38.6M (−8.7%) vs. Q4 2021
- New holders
- 5
- 12 more added
- Sold out
- 4
- 15 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 70 | $145.8M |
| Q3 2023 | 63 | $95.5M |
| Q2 2023 | 69 | $373.6M |
| Q1 2023 | 72 | $350.6M |
| Q4 2022 | 47 | $164.8M |
| Q3 2022 | 51 | $200.7M |
| Q2 2022 | 51 | $191.6M |
| Q1 2022 | 47 | $402.8M |
| Q4 2021 | 46 | $441.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 17,041,668 | $196.5M | 3.19% | +203,000+1.2% | Added |
| FMR LLC | 5,557,447 | $64.1M | 0.01% | +108,778+2.0% | Added |
| Foresite Capital Management V, LLC | 3,212,732 | $37.0M | 15.13% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,436,616 | $16.3M | 0.00% | +137,129+10.6% | Added |
| Boxer Capital, LLC | 892,057 | $10.3M | 0.53% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 761,589 | $8.78M | 0.02% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 711,479 | $8.20M | 1.68% | 00.0% | Unchanged |
| Nextech Invest AG | 611,310 | $7.05M | 2.01% | 00.0% | Unchanged |
| BlackRock Inc. | 544,855 | $6.28M | 0.00% | +11,592+2.2% | Added |
| Farallon Capital Management, L.L.C. | 523,979 | $6.04M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 486,362 | $5.61M | 0.00% | −396−0.1% | Reduced |
| Foresite Capital Opportunity Management V, LLC | 468,820 | $5.41M | 7.57% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 437,329 | $5.04M | 0.13% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 356,827 | $4.11M | 3.82% | −52,531−12.8% | Reduced |
| Wellington Management Group LLP | 293,587 | $3.38M | 0.00% | −331,233−53.0% | Reduced |
| Ensign Peak Advisors, Inc | 250,000 | $2.88M | 0.01% | 00.0% | Unchanged |
| Woodline Partners LP | 250,000 | $2.88M | 0.05% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 202,436 | $2.33M | 0.00% | +10,389+5.4% | Added |
| State Street Corp | 182,661 | $2.11M | 0.00% | +55,865+44.1% | Added |
| Laurion Capital Management LP | 179,619 | $2.07M | 0.05% | −25,402−12.4% | Reduced |
| Tekla Capital Management LLC | 100,000 | $1.15M | 0.04% | 00.0% | Unchanged |
| Northern Trust Corp | 97,139 | $1.12M | 0.00% | +255+0.3% | Added |
| DAFNA Capital Management LLC | 80,124 | $924.0K | 0.24% | −17,376−17.8% | Reduced |
| TD Asset Management Inc | 67,133 | $774.0K | 0.00% | +10,931+19.4% | Added |
| Manufacturers Life Insurance Company, The | 59,923 | $701.3K | 0.00% | +59,923 | New |
| Charles Schwab Investment Management Inc | 32,229 | $372.0K | 0.00% | +1,285+4.2% | Added |
| Bank of New York Mellon Corp | 29,379 | $338.0K | 0.00% | +12,219+71.2% | Added |
| Nuveen Asset Management, LLC | 17,494 | $202.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 9,648 | $111.0K | 0.00% | −31−0.3% | Reduced |
| New York State Common Retirement Fund | 9,495 | $109.0K | 0.00% | +7,844+475.1% | Added |
| Deutsche Bank AG | 6,253 | $72.0K | 0.00% | −740−10.6% | Reduced |
| Barclays PLC | 6,210 | $72.0K | 0.00% | +6,210 | New |
| American International Group, Inc. | 5,714 | $66.0K | 0.00% | −402−6.6% | Reduced |
| JPMorgan Chase & Co | 5,397 | $62.0K | 0.00% | +289+5.7% | Added |
| Bank of America Corp | 5,074 | $59.0K | 0.00% | −2,832−35.8% | Reduced |
| California State Teachers Retirement System | 4,926 | $57.0K | 0.00% | −1,399−22.1% | Reduced |
| STRS Ohio | 2,700 | $31.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,499 | $29.0K | 0.00% | −4,275−63.1% | Reduced |
| UBS Group AG | 2,041 | $24.0K | 0.00% | −1,527−42.8% | Reduced |
| Amalgamated Bank | 1,670 | $19.0K | 0.00% | +1,670 | New |
| Amalgamated Financial Corp. | 1,670 | $19.0K | 0.00% | +1,670 | New |
| Tower Research Capital LLC (TRC) | 1,408 | $16.0K | 0.00% | −712−33.6% | Reduced |
| High Net Worth Advisory Group LLC | 1,300 | $15.0K | 0.01% | +1,300 | New |
| Legal & General Group Plc | 1,059 | $12.0K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 889 | $10.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 707 | $8.00K | 0.00% | −1,575−69.0% | Reduced |
| Citigroup Inc | 449 | $5.00K | 0.00% | −2,698−85.7% | Reduced |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −22,136−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −11,340−100.0% | Sold out |